Description     Claims     Drawing  

US20040248203A   [0008] 
US5876956A   [0016]  [0021] 
US6991897B   [0016]  [0021]  [0037] 

Isolation of primitive huma hematopoietic progenitors on the basis of aldehyde dehydrogenase activity   [0007] 
The Molecular Probes Handbook--A Guide to Fluorescent Probes and Labeling Technologies   [0027] 
Remington: The Science and Practice of Pharmacy   [0042]  [0043] 
Pharmaceutical Salts   [0125] 
Protective Groups in Organic Synthesis   [0126] 
J Org. Chem.   [0137] 
Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity   [0156] 
Concise review: aldehyde dehydrogenase bright stem and progenitor cell populations from normal tissues: characteristics, activities, and emerging uses in regenerative medicine   [0156] 
Hematopoietic stem cells: to be or Notch to be   [0156] 
Human aldehyde dehydrogenase genes: alternatively spliced transcriptional variants and their suggested nomenclature   [0156] 
ABC transporters as phenotypic markers and functional regulators of stem cells   [0156] 
Reprogrammed Cells for Disease Modeling and Regenerative Medicine   [0156] 
Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance   [0156] 
Induced Pluripotent Stem Cells as a Disease Modeling and Drug Screening Platform   [0156] 
Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function   [0156] 
A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia   [0156] 
Charge-Shift Probes of Membrane-Potential - Synthesis   [0156] 
Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity   [0156] 
Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia   [0156] 
The Use of Induced Pluripotent Stem Cells in Drug Development   [0156] 
Assessment of aldehyde dehydrogenase in viable cells   [0156] 
Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems   [0156] 
The role of human aldehyde dehydrogenase in normal and cancer stem cells   [0156] 
Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily   [0156] 
Embryonic retinoic acid synthesis is essential for early mouse post-implantation development   [0156] 
Notch signaling in mammalian hematopoietic stem cells   [0156] 
The combined use of Hoechst efflux ability and aldehyde dehydrogenase activity to identify murine and human hematopoietic stem cells   [0156] 
Isolation and characterization of centroacinar/terminal ductal progenitor cells in adult mouse pancreas   [0156] 
Practical flow cytometry   [0156] 
Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling system   [0156] 
Human Pluripotent Stem Cells for Modeling Toxicity   [0156] 
Synthesis of protein-reactive (aminostyryl)pyridinium dyes   [0156] 
Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity   [0156] 
Diseases in a dish: modeling human genetic disorders using induced pluripotent cells   [0156] 
Targeting aldehyde dehydrogenase: a potential approach for cell labeling   [0156] 
Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism   [0156] 
Synthesis, spectra, delivery and potentiometric responses of new styryl dyes with extended spectral ranges   [0156] 
Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay   [0156]